COVID-19 Vaccines for Moderately to Severely Immunocompromised People
CDC recommends that moderately or severely immunocompromised people receive an additional dose of mRNA COVID-19 vaccine at least four weeks after a second dose of Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine. 2019 Novel Coronavirus